SCHEMBL30844318

SCHEMBL30844318

CC(C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C

nearest known ligand 0.63

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ EPHA2 P29317 2/20 0.63
▸ KDM1A O60341 3/20 0.61
▸ MAOB P27338 1/20 0.61
▸ KDM5A P29375 1/20 0.61
▸ KDM1B Q8NB78 1/20 0.61
▸ NPY2R P49146 7/20 0.61
▸ NPY4R P50391 7/20 0.61
▸ NPY5R Q15761 7/20 0.61
▸ NPY1R P25929 5/20 0.61
▸ TFPI P10646 6/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30844294 1.00 EPHA2 (0.63) EPHA2KDM1AMAOBKDM5AKDM1B
SCHEMBL30844258 1.00 EPHA2 (0.63) EPHA2KDM1AMAOBKDM5AKDM1B
SCHEMBL30844362 1.00 EPHA2 (0.63) EPHA2KDM1AMAOBKDM5AKDM1B
SCHEMBL30844350 0.96 KDM1A (0.62) EPHA2KDM1AMAOBKDM5AKDM1B
SCHEMBL30844338 0.94 NPY2R (0.60) EPHA2KDM1AMAOBKDM5AKDM1B
SCHEMBL30401038 0.93 NPY2R (0.66) KDM1AMAOBKDM5AKDM1BNPY2R
SCHEMBL30844261 0.92 NPY2R (0.50) EPHA2KDM1AMAOBKDM5AKDM1B
SCHEMBL31257146 0.92 NPY2R (0.50) EPHA2KDM1AMAOBKDM5AKDM1B
SCHEMBL30844284 0.92 NPY2R (0.50) EPHA2KDM1AMAOBKDM5AKDM1B
SCHEMBL30844276 0.92 NPY2R (0.50) EPHA2KDM1AMAOBKDM5AKDM1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250101063-A1 POLYPEPTIDE COMPOUND AND USE THEREOF IN TREATMENT OF ENTERITIS SICHUAN GOODDOCTOR PANXI PHARMACEUTICAL CO., LTD. (CN) 2025-03-27 — — US claimed
EP-4467562-A1 POLYPEPTIDE COMPOUND AND USE THEREOF IN TREATMENT OF ENTERITIS Sichuan Gooddoctor Panxi Pharmaceutical Co. Ltd (CN) 2024-11-27 — — EP claimed
CN-117858890-A Polypeptide compound and application thereof in treating enteritis 四川好医生攀西药业有限责任公司 2024-04-09 — — CN claimed
US-20250101063-A1 POLYPEPTIDE COMPOUND AND USE THEREOF IN TREATMENT OF ENTERITIS SICHUAN GOODDOCTOR PANXI PHARMACEUTICAL CO., LTD. (CN) 2025-03-27 — — US disclosed
EP-4467562-A1 POLYPEPTIDE COMPOUND AND USE THEREOF IN TREATMENT OF ENTERITIS Sichuan Gooddoctor Panxi Pharmaceutical Co. Ltd (CN) 2024-11-27 — — EP disclosed
CN-117858890-A Polypeptide compound and application thereof in treating enteritis 四川好医生攀西药业有限责任公司 2024-04-09 — — CN disclosed
Send feedback